Evidence map›Paper›PMID 20381335›Full record

ReviewCurrent opinion in genetics & development2010

Targeting X chromosomes for repression.

Barbara J Meyer

Abstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
3.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Dosage compensation evolution in plants: theories, controversies and mechanisms.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Rapid regulatory evolution of a nonrecombining autosome linked to divergent behavioral phenotypes.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Repressive Chromatin inGenetics · 2018
    Review
  13. Review
  14. Article
  15. Mutation ofGenes & development · 2017
    Article
  16. Meiosis.WormBook : the online review of C. elegans biology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Dynamic Control of Chromosome Topology and Gene Expression by a Chromatin Modification.Cold Spring Harbor symposia on quantitative biology · 2017
    Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Barbara J MeyerHHMI and U.C. Berkeley, Department of Molecular and Cell Biology, Berkeley, CA 94720-3704, United States. bjmeyer@berkeley.edu <bjmeyer@berkeley.edu>
University of California, Berkeley · US

Funding

NEMATODE SEX DETERMINATIONR01GM030702 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MEYER, BARBARA J · 1985 to 2018
$6.1M
NEMATODE SEX DETERMINATIONR37GM030702 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MEYER, BARBARA J · 1995 to 2004
$2.0M
NIGMS NIH HHS GM30702NIGMS NIH HHS R01 GM030702NIGMS NIH HHS R37 GM030702
6 · The paper itself

Abstract

Dosage compensation is a chromosome-wide regulatory process that balances X-chromosome gene expression between males and females that have different complements. Recent advances have clarified the molecular nature of the Caenorhabditis elegans sex-determination signal, which tallies X-chromosome number relative to the ploidy and controls both the choice of sexual fate and the process of dosage compensation. Dissecting the sex signal has revealed molecular mechanisms by which small quantitative differences in intracellular signals are translated into dramatically different developmental fates. Recent experiments have also revealed fundamental principles by which C. elegans dosage compensation proteins recognize and bind X chromosomes of XX embryos to reduce gene expression. Dosage compensation proteins function not only in a condensin complex specialized for regulating X-chromosome gene expression, but also in distinct condensin complexes that control other chromosome-wide processes: chromosome segregation and meiotic crossover recombination. The reshuffling of interchangeable molecular parts creates independent machines with similar architecture but distinct biological functions.

Indexed as

Dosage Compensation, GeneticAdenosine TriphosphatasesAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsDNA-Binding ProteinsFemaleGenes, X-LinkedMaleModels, GeneticMultiprotein ComplexesX ChromosomeAdenosine TriphosphatasesCaenorhabditis elegans Proteinscondensin complexesDNA-Binding ProteinsMultiprotein Complexes

Identifiers

PMID20381335
PMCPMC2906122
OpenAlexW2000045735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.